AVR 1.29% $18.31 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-533

  1. 1,533 Posts.
    lightbulb Created with Sketch. 300
    like I have said since I bought back in for me it’s a punt at these buy in prices so far I have accumulated close to 1 million shares If AHZ can raise some capital via infusion sale , Cardiocell, Vascucel sales or just reaching that 8 c mark they should theoretically bounce back to around 20c per share . I am personally hoping Cardio Cell and VascuCel can achive some decent sales in Europe , it’s a little bit of a different ball game over there compared to the US . In the US health insurance companies have deals with companies like Edwards to supply their products which might make AHZ US targets harder to achive . I don’t know what the situation is over in Europe but hopefully AHZ can make some inroads . Like I said all along it’s a punt but one I am reasonably confident will pay of
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.31
Change
-0.240(1.29%)
Mkt cap ! $351.9M
Open High Low Value Volume
$18.80 $19.15 $18.20 $159.7K 8.611K

Buyers (Bids)

No. Vol. Price($)
1 73 $18.31
 

Sellers (Offers)

Price($) Vol. No.
$18.33 90 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.